According to Merck's latest financial reports the company's current EPS (TTM) is $2.39. In 2022 the company made an earnings per share (EPS) of $7.51 an increase over its 2021 EPS that were of $6.77.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $2.44 | -67.53% |
2022 | $7.51 | 10.92% |
2021 | $6.77 | 84.68% |
2020 | $3.67 | -27.2% |
2019 | $5.04 | 63.44% |
2018 | $3.08 | 151.11% |
2017 | $1.23 | -54.58% |
2016 | $2.70 | 30.21% |
2015 | $2.07 | -61.99% |
2014 | $5.46 | 180.51% |
2013 | $1.95 | -31.82% |
2012 | $2.85 | 6.62% |
2011 | $2.68 | 626.78% |
2010 | $0.37 | -95.05% |
2009 | $7.44 | 56.36% |
2008 | $4.76 | -449.04% |
2007 | -$1.36 | -150.98% |
2006 | $2.67 | -3.32% |
2005 | $2.77 | -20.08% |
2004 | $3.46 | -10.81% |
2003 | $3.88 | -6.92% |
2002 | $4.17 | 0% |
2001 | $4.17 | 7.43% |
2000 | $3.88 | 17.93% |
1999 | $3.29 | 13.06% |
1998 | $2.91 | 15.63% |
1997 | $2.52 | 20% |
1996 | $2.10 |